New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during staphylococcus aureus invasive infections to humans

Journal of Medical Microbiology

Volumn 64, Issue 4, 2015, Pages 335-343

  Elkhatib, Walid F ^a,b,c   Hair, Pamela S ^c   Nyalwidhe, Julius O ^c   Cunnion, Kenji M ^c,d,e  

^a HAMPTON UNIVERSITY   (United States)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d Children's Specialty Group   (United States)

^e Children's Hospital of The King's Daughters   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BACTERIAL PROTEIN; CLFA PROTEIN; FACTOR A; UNCLASSIFIED DRUG; VIRULENCE FACTOR; CLFA PROTEIN, STAPHYLOCOCCUS AUREUS; COAGULASE; PROTEIN BINDING;

ARTICLE; BACTERIAL CELL; BACTERIAL CELL WALL; CONTROLLED STUDY; CORRELATION COEFFICIENT; HOST RESISTANCE; HUMAN; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS; STOICHIOMETRY; BACTERIUM ADHERENCE; GENE DELETION; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

APOLIPOPROTEINS E; BACTERIAL ADHESION; COAGULASE; GENE DELETION; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BINDING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84927741379     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000010     Document Type: Article

References (43)

1. Arciola, C. R., Baldassarri, L. & Montanaro, L. (2001). Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol 39, 2151–2156.
2. Bur, S., Preissner, K. T., Herrmann, M. & Bischoff, M. (2013). The Staphylococcus aureus extracellular adherence protein promotes bacterial internalization by keratinocytes independent of fibronectin- binding proteins. J Invest Dermatol 133, 2004–2012.
3. Cunnion, K. M., Lee, J. C. & Frank, M. M. (2001). Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun 69, 6796–6803.
4. de Bont, N., Netea, M. G., Demacker, P. N., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. & Stalenhoef, A. F. (1999). Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 40, 680–685.
5. Dhaliwal, W., Kelly, P. & Bajaj-Elliott, M. (2009). Differential effects of staphylococcal enterotoxin B-mediated immune activation on intestinal defensins. Clin Exp Immunol 156, 263–270.
6. Do Carmo, S., Jacomy, H., Talbot, P. J. & Rassart, E. (2008). Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. J Neurosci 28, 10330–10338.
7. Dobson, C. B., Sales, S. D., Hoggard, P., Wozniak, M. A. & Crutcher, K. A. (2006). The receptor-binding region of human apolipoprotein E has direct anti-infective activity. J Infect Dis 193, 442–450.
8. Faghri, J., Shahbazzadeh, D., Pooshang Bagheri, K., Moghim, S., Ghasemian Safaei, H., Nasr Esfahani, B., Fazeli, H., Yazdani, R. & Mirmohammad Sadeghi, H. (2012). Two dimensional structural analysis and expression of a new Staphylococcus aureus adhesin based fusion protein. Iran J Basic Med Sci 15, 725–738.
9. Forbes, S., McBain, A. J., Felton-Smith, S., Jowitt, T. A., Birchenough, H. L. & Dobson, C. B. (2013). Comparative surface antimicrobial properties of synthetic biocides and novel human apolipoprotein E derived antimicrobial peptides. Biomaterials 34, 5453–5464.
10. Friberg, N., Carlson, P., Kentala, E., Mattila, P. S., Kuusela, P., Meri, S. & Jarva, H. (2008). Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum. J Immunol 181, 8624–8632.
11. Hair, P. S., Ward, M. D., Semmes, O. J., Foster, T. J. & Cunnion, K. M. (2008). Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis 198, 125–133.
12. Hair, P. S., Echague, C. G., Sholl, A. M., Watkins, J. A., Geoghegan, J. A., Foster, T. J. & Cunnion, K. M. (2010). Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complementmediated phagocytosis. Infect Immun 78, 1717–1727.
13. Hair, P. S., Foley, C. K., Krishna, N. K., Nyalwidhe, J. O., Geoghegan, J. A., Foster, T. J. & Cunnion, K. M. (2013). Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing. Results Immunol 3, 114–121.
14. Hakim, H., Mylotte, J. M. & Faden, H. (2007). Morbidity and mortality of staphylococcal bacteremia in children. Am J Infect Control 35, 102–105.
15. Haupt, K., Reuter, M., van den Elsen, J., Burman, J., Hälbich, S., Richter, J., Skerka, C. & Zipfel, P. F. (2008). The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement factor H and C3b. PLoS Pathog 4, e1000250.
16. Hawkins, J., Kodali, S., Matsuka, Y. V., McNeil, L. K., Mininni, T., Scully, I. L., Vernachio, J. H., Severina, E., Girgenti, D. & other authors (2012). A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure. Clin Vaccine Immunol 19, 1641–1650.
17. Hu, D. L., Narita, K., Hyodo, M., Hayakawa, Y., Nakane, A. & Karaolis, D. K. (2009). c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection. Vaccine 27, 4867–4873.
18. James, E. H., Edwards, A. M. & Wigneshweraraj, S. (2013). Transcriptional downregulation of agr expression in Staphylococcus aureus during growth in human serum can be overcome by constitutively active mutant forms of the sensor kinase AgrC. FEMS Microbiol Lett 349, 153–162.
19. Jofre-Monseny, L., Minihane, A. M. & Rimbach, G. (2008). Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52, 131–145.
20. Josefsson, E., Hartford, O., O’Brien, L., Patti, J. M. & Foster, T. (2001). Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 184, 1572–1580.
21. Kerrigan, S. W., Clarke, N., Loughman, A., Meade, G., Foster, T. J. & Cox, D. (2008). Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler Thromb Vasc Biol 28, 335–340.
22. Kuwahara, T., Kaneda, S., Shimono, K. & Inoue, Y. (2010). Growth of microorganisms in total parenteral nutrition solutions without lipid. Int J Med Sci 7, 43–47.
23. Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. (2013). Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9, 106–118.
24. Martens, G. W., Arikan, M. C., Lee, J., Ren, F., Vallerskog, T. & Kornfeld, H. (2008). Hypercholesterolemia impairs immunity to tuberculosis. Infect Immun 76, 3464–3472.
25. Masago, Y., Shibata, T. & Rose, J. B. (2008). Bacteriophage P22 and Staphylococcus aureus attenuation on nonporous fomites as determined by plate assay and quantitative PCR. Appl Environ Microbiol 74, 5838–5840.
26. McAdow, M., Kim, H. K., Dedent, A. C., Hendrickx, A. P., Schneewind, O. & Missiakas, D. M. (2011). Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog 7, e1002307.
27. McCormack, N., Foster, T. J. & Geoghegan, J. A. (2014). A short sequence within subdomain N1 of region A of the Staphylococcus aureus MSCRAMM clumping factor A is required for export and surface display. Microbiology 160, 659–670.
28. McDevitt, D., Francois, P., Vaudaux, P. & Foster, T. J. (1994). Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 11, 237–248.
29. Miajlovic, H., Fallon, P. G., Irvine, A. D. & Foster, T. J. (2010). Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 126, 1184–1190.
30. Moreillon, P., Entenza, J. M., Francioli, P., McDevitt, D., Foster, T. J., Franҫois, P. & Vaudaux, P. (1995). Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 63, 4738–4743.
31. Palmqvist, N., Patti, J. M., Tarkowski, A. & Josefsson, E. (2004). Expression of staphylococcal clumping factor A impedes macrophage phagocytosis. Microbes Infect 6, 188–195.
32. Peterson, M. M., Mack, J. L., Hall, P. R., Alsup, A. A., Alexander, S. M., Sully, E. K., Sawires, Y. S., Cheung, A. L., Otto, M. & Gresham, H. D. (2008). Apolipoprotein B is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe 4, 555–566.
33. Roselaar, S. E. & Daugherty, A. (1998). Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 39, 1740–1743.
34. Rosenthal, V. D., Maki, D. G., Jamulitrat, S., Medeiros, E. A., Todi, S. K., Gomez, D. Y., Leblebicioglu, H., Abu Khader, I., Miranda Novales, M. G. & other authors (2010). International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 38, 95–104, e2.
35. Sharp, J. A. & Cunnion, K. M. (2011). Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus. Mol Immunol 48, 683–690.
36. Sharp, J. A., Echague, C. G., Hair, P. S., Ward, M. D., Nyalwidhe, J. O., Geoghegan, J. A., Foster, T. J. & Cunnion, K. M. (2012). Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic. PLoS ONE 7, e38407.
37. Sigel, S., Bunk, S., Meergans, T., Doninger, B., Stich, K., Stulnig, T., Derfler, K., Hoffmann, J., Deininger, S. & other authors (2012). Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice. Eur J Immunol 42, 2983–2989.
38. Singh, I. P., Chopra, A. K., Coppenhaver, D. H., Ananatharamaiah, G. M. & Baron, S. (1999). Lipoproteins account for part of the broad non-specific antiviral activity of human serum. Antiviral Res 42, 211–218.
39. Tada, N., Sakamoto, T., Kagami, A., Mochizuki, K. & Kurosaka, K. (1993). Antimicrobial activity of lipoprotein particles containing apolipoprotein Al. Mol Cell Biochem 119, 171–178.
40. Tanaka, N., Abe-Dohmae, S., Iwamoto, N., Fitzgerald, M. L. & Yokoyama, S. (2010). Helical apolipoproteins of high-density lipoprotein enhance phagocytosis by stabilizing ATP-binding cassette transporter A7. J Lipid Res 51, 2591–2599.
41. Van Oosten, M., Rensen, P. C., Van Amersfoort, E. S., Van Eck, M., Van Dam, A. M., Breve, J. J., Vogel, T., Panet, A., Van Berkel, T. J. & Kuiper, J. (2001). Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem 276, 8820–8824.
42. Walsh, E. J., O’Brien, L. M., Liang, X., Hook, M. & Foster, T. J. (2004). Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. J Biol Chem 279, 50691–50699.
43. Zhang, H., Wu, L.-M. & Wu, J. (2011). Cross-talk between apolipoprotein E and cytokines. Mediators Inflamm 2011, 949072.